These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 24388887)

  • 1. Chronic NG-nitro-l-arginine methyl ester (L-NAME) administration in C57BL/6J mice induces a sustained decrease in c-kit positive cells during development of cardiac hypertrophy.
    Ocsan RJ; Lai YN; Prabhu KV; Hambly BD; McLachlan CS
    J Physiol Pharmacol; 2013 Dec; 64(6):727-36. PubMed ID: 24388887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Celiprolol, a vasodilatory beta-blocker, inhibits pressure overload-induced cardiac hypertrophy and prevents the transition to heart failure via nitric oxide-dependent mechanisms in mice.
    Liao Y; Asakura M; Takashima S; Ogai A; Asano Y; Shintani Y; Minamino T; Asanuma H; Sanada S; Kim J; Kitamura S; Tomoike H; Hori M; Kitakaze M
    Circulation; 2004 Aug; 110(6):692-9. PubMed ID: 15262839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regression of chronic L -NAME-treatment-induced left ventricular hypertrophy: effect of captopril.
    Bernátová I; Pechánová O; Pelouch V; Simko F
    J Mol Cell Cardiol; 2000 Feb; 32(2):177-85. PubMed ID: 10722795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-acting Ca2+ blockers prevent myocardial remodeling induced by chronic NO inhibition in rats.
    Sanada S; Node K; Minamino T; Takashima S; Ogai A; Asanuma H; Ogita H; Liao Y; Asakura M; Kim J; Hori M; Kitakaze M
    Hypertension; 2003 Apr; 41(4):963-7. PubMed ID: 12629037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of cardiomyocyte hypotrophy in rats under prolonged treatment with a low dose of a nitric oxide synthesis inhibitor.
    de Oliveira CF; Cintra KA; Teixeira SA; De Luca IM; Antunes E; De Nucci G
    Eur J Pharmacol; 2000 Mar; 391(1-2):121-6. PubMed ID: 10720643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melatonin prevents fibrosis but not hypertrophy development in the left ventricle of NG-nitro-L-arginine-methyl ester hypertensive rats.
    Paulis L; Pechanova O; Zicha J; Krajcirovicova K; Barta A; Pelouch V; Adamcova M; Simko F
    J Hypertens Suppl; 2009 Aug; 27(6):S11-6. PubMed ID: 19633445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of angiotensin-converting enzyme 2 in cardiac hypertrophy induced by nitric oxide synthase inhibition.
    Inaba S; Iwai M; Furuno M; Kanno H; Senba I; Okayama H; Mogi M; Higaki J; Horiuchi M
    J Hypertens; 2011 Nov; 29(11):2236-45. PubMed ID: 21946695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulation of adrenomedullin and its receptor components during cardiomyocyte hypertrophy induced by chronic inhibition of nitric oxide synthesis in rats.
    Bell D; Zhao YY; Kelso EJ; McHenry EM; Rush LM; Lamont VM; Nicholls DP; McDermott BJ
    Am J Physiol Heart Circ Physiol; 2006 Feb; 290(2):H904-14. PubMed ID: 16040721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The stereology of the myocardium in rats hypertensive due to the use of an inhibitor of nitric oxide synthesis].
    Pereira LM; Mandarim-de-Lacerda CA
    Rev Port Cardiol; 1997 Oct; 16(10):753-9, 743. PubMed ID: 9479938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regression of left ventricular hypertrophy and aortic remodelling in NO-deficient hypertensive rats: effect of L-arginine and spironolactone.
    Paulis L; Matuskova J; Adamcova M; Pelouch V; Simko J; Krajcirovicova K; Potacova A; Hulin I; Janega P; Pechanova O; Simko F
    Acta Physiol (Oxf); 2008 Sep; 194(1):45-55. PubMed ID: 18419778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct roles of nitric oxide synthases and interstitial cells of Cajal in rectoanal relaxation.
    Terauchi A; Kobayashi D; Mashimo H
    Am J Physiol Gastrointest Liver Physiol; 2005 Aug; 289(2):G291-9. PubMed ID: 15845873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Opening of ATP-sensitive potassium channel attenuates cardiac remodeling induced by chronic inhibition of nitric oxide synthesis].
    Sanada S; Node K; Asanuma H; Ogita H; Takashima S; Minamino T; Asakura M; Hori M; Kitakaze M
    J Cardiol; 2003 Jan; 41(1):43-4. PubMed ID: 12564115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin II type 1 receptor blocker prevents atrial structural remodeling in rats with hypertension induced by chronic nitric oxide inhibition.
    Okazaki H; Minamino T; Tsukamoto O; Kim J; Okada K; Myoishi M; Wakeno M; Takashima S; Mochizuki N; Kitakaze M
    Hypertens Res; 2006 Apr; 29(4):277-84. PubMed ID: 16778335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of endothelial nitric oxide synthase induces and enhances myocardial fibrosis.
    Kazakov A; Hall R; Jagoda P; Bachelier K; Müller-Best P; Semenov A; Lammert F; Böhm M; Laufs U
    Cardiovasc Res; 2013 Nov; 100(2):211-21. PubMed ID: 23863197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effects of BAY 41-2272 (sGC stimulator) on hypertension, heart, and cardiomyocyte hypertrophy induced by chronic L-NAME treatment in rats.
    Zanfolin M; Faro R; Araujo EG; Guaraldo AM; Antunes E; De Nucci G
    J Cardiovasc Pharmacol; 2006 Mar; 47(3):391-5. PubMed ID: 16633081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heart remodeling in the hereditary hypertriglyceridemic rat: effect of captopril and nitric oxide deficiency.
    Simko F; Luptak I; Matuskova J; Babal P; Pechanova O; Bernatova I; Hulin I
    Ann N Y Acad Sci; 2002 Jun; 967():454-62. PubMed ID: 12079874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ability of phosphodiesterase-5 inhibitors sildenafil and ordonafil to reverse L-NAME induced cardiac hypertrophy in the rabbit: possible role of calcineurin and p38.
    Zeidan A; Siam A; Al Kaabba A; Mohammad M; Khatib S
    Can J Physiol Pharmacol; 2012 Sep; 90(9):1247-55. PubMed ID: 22913522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study of L-NAME treatment on experimental autoimmune myocarditis].
    Ding GL; Han LN; Wang YT; Liu JW; He S; Zou X
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2013 Mar; 29(2):119-23. PubMed ID: 23833961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of nitric oxide synthase by L-NAME improves ventricular performance in streptozotocin-diabetic rats.
    Smith JM; Paulson DJ; Romano FD
    J Mol Cell Cardiol; 1997 Sep; 29(9):2393-402. PubMed ID: 9299363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic N(G)-nitro-L-arginine methyl ester-induced hypertension : novel molecular adaptation to systolic load in absence of hypertrophy.
    Bartunek J; Weinberg EO; Tajima M; Rohrbach S; Katz SE; Douglas PS; Lorell BH
    Circulation; 2000 Feb; 101(4):423-9. PubMed ID: 10653835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.